Clear Street’s ZyVersa Therapeutics ZVSA Stock Holding History

Clear Street’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	-$4K	–	1164
2022 Q3	$4K	Buy	+1	New	+$3.49K	﹤0.01%	839
2022 Q2	–	Hold	0	–	–	–	925

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Clear Street's ZVSA Position: Q4 2022 in Review

Clear Street sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1 share — an estimated $4K sold.

Clear Street first reported a position in ZVSA in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Clear Street reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Clear Street sold 1 ZyVersa Therapeutics share in Q4 2022, an estimated $4K.
Clear Street first reported a position in ZyVersa Therapeutics in Q3 2022 and held it in 1 quarter.
Clear Street's ZyVersa Therapeutics position peaked at $4K in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.